ADVANCED SOLID TUMOR

This is an early safety study for a new drug called BSI-082, designed for adults with advanced solid tumors that have spread or stopped responding to standard treatments. The study has two parts: first testing BSI-082 alone at increasing doses, then testing it combined with anoth…

This is a first-in-human study to test the safety and find the right dose of a new experimental drug called ONC-783. It will involve about 20 adults with advanced solid tumors, focusing on colorectal, ovarian, pancreatic, or breast cancers. The drug is designed to guide the body'…

This is the first study in people to test a new drug called MG2512 injection for advanced solid tumors that have stopped responding to standard treatments. Researchers will give the drug to about 116 adults to check its safety, how the body processes it, and look for early signs …

This is the first time researchers are testing the experimental drug ISM5939 in people. The study aims to find a safe and effective dose for patients with advanced or metastatic solid tumors that have stopped responding to standard treatments. Researchers will first test the drug…

This study aims to find a safe and effective dose for a new cancer drug called SHR-4375 when used alongside other cancer treatments. It is for adults with advanced solid tumors that have not responded to standard therapies. The main goals are to check for side effects and see if …

This early-stage clinical trial aims to test the safety and find the best dose of a new investigational drug, CVL006, when given in combination with several other established cancer therapies. It will involve about 318 adults with advanced solid tumors that have not responded to …

This is the first study in people to test a new drug called SHR-1049 injection for patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, check for side effects, and see how the body processes the drug. Res…

This early-stage study is testing a new oral medication called ZL-85FA in adults with advanced solid tumors, including certain breast, ovarian, and prostate cancers. The main goals are to check the drug's safety, how the body processes it, and to see if it can shrink or control t…

This early-stage study is testing a new, personalized cell therapy called CAT-101 for people with advanced solid tumors that have specific KRAS gene mutations. The therapy involves taking a patient's own immune cells, training them to target the cancer, and then reinfusing them, …

This is a first-in-human study testing a new oral drug called ACC-1898 in adults with advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose and understand how the body processes the drug. Researchers will also look for early …

This is the first human study of an experimental cancer drug called BG-C0979. Researchers will test its safety and how the body processes it in people with advanced solid tumors that have stopped responding to standard treatments. The study will also look for early signs that the…